Corpe Christopher P, Lee Je-Hyuk, Kwon Oran, Eck Peter, Narayanan Jayan, Kirk Kenneth L, Levine Mark
Molecular and Clinical Nutrition Section, Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, MD 20892-1372, USA.
J Biol Chem. 2005 Feb 18;280(7):5211-20. doi: 10.1074/jbc.M412925200. Epub 2004 Dec 6.
Vitamin C intracellular accumulation is mediated by Na(+)-dependent vitamin C transporters SVCT1 and -2 and dehydroascorbic acid transporters GLUT1 and -3. It is unclear which pathways dominate in vivo. As a new step to resolve this issue, we identified and tested 6-bromo-6-deoxy-L-ascorbic acid as a specific candidate for SVCTs. In high performance liquid chromatography and electron paramagnetic resonance analyses, the reduced compounds ascorbic acid and 6-bromo-6-deoxy-L-ascorbic acid were similar. The oxidized products 6-bromo-6-deoxy dehydroascorbic acid (BrDHA) and dehydroascorbic acid (DHA) had comparable stabilities, based on reduction recoveries. Upon expression of GLUT1 or GLUT3 in Xenopus oocytes, BrDHA was neither transported nor bound, in contrast to robust transport of DHA. The findings were not explained by differences in the oocyte reduction of DHA and BrDHA because lysed oocytes reduced both compounds equally. Further, there was no transport of the reduced compound, 6-bromo-6-deoxy-L-ascorbic acid, by GLUT1 or GLUT3. As a prerequisite for investigating 6-bromo-6-deoxy-L-ascorbic acid transported by SVCTs, SVCT2 transport activity in oocytes was enhanced 14-fold by construction and use of a vector that added a fixed poly(A) tail to the 3' end of cRNA. For SVCT1 and SVCT2 expressed in oocytes, similar K(m) and V(max) values were observed for ascorbic acid and 6-bromo-6-deoxy-L-ascorbic acid. In human fibroblasts, predicted to have SVCT-mediated ascorbate accumulation, K(m) and V(max) values were again comparable for ascorbic acid and 6-bromo-6-deoxy-L-ascorbic acid. Using activated human neutrophils, predicted to have ascorbate accumulation mediated predominantly by DHA and GLUT transporters, 6-bromo-6-deoxy-L-ascorbic acid accumulation was <1% of accumulation when compared with ascorbic acid. We conclude that 6-bromo-6-deoxy-L-ascorbic acid is the first transport substrate identified as completely specific for SVCTs, but not GLUTs, and provide a new strategy to determine the contribution of each pathway to ascorbate accumulation.
维生素C的细胞内积累由钠离子依赖性维生素C转运体SVCT1和SVCT2以及脱氢抗坏血酸转运体GLUT1和GLUT3介导。目前尚不清楚在体内哪种途径起主导作用。作为解决这一问题的新步骤,我们鉴定并测试了6-溴-6-脱氧-L-抗坏血酸作为SVCTs的特异性候选物。在高效液相色谱和电子顺磁共振分析中,还原型化合物抗坏血酸和6-溴-6-脱氧-L-抗坏血酸相似。基于还原回收率,氧化产物6-溴-6-脱氧脱氢抗坏血酸(BrDHA)和脱氢抗坏血酸(DHA)具有相当的稳定性。在非洲爪蟾卵母细胞中表达GLUT1或GLUT3时,与DHA的强大转运相反,BrDHA既不被转运也不被结合。卵母细胞对DHA和BrDHA的还原差异并不能解释这一发现,因为裂解的卵母细胞对这两种化合物的还原程度相同。此外,GLUT1或GLUT3对还原型化合物6-溴-6-脱氧-L-抗坏血酸没有转运作用。作为研究SVCTs转运的6-溴-6-脱氧-L-抗坏血酸的前提,通过构建并使用一种在cRNA的3'末端添加固定聚腺苷酸尾巴的载体,卵母细胞中的SVCT2转运活性提高了14倍。对于卵母细胞中表达的SVCT1和SVCT2,抗坏血酸和6-溴-6-脱氧-L-抗坏血酸的K(m)和V(max)值相似。在预计具有SVCT介导的抗坏血酸积累的人成纤维细胞中,抗坏血酸和6-溴-6-脱氧-L-抗坏血酸的K(m)和V(max)值再次相当。在预计主要由DHA和GLUT转运体介导抗坏血酸积累的活化人中性粒细胞中,与抗坏血酸相比,6-溴-6-脱氧-L-抗坏血酸的积累量<1%。我们得出结论,6-溴-6-脱氧-L-抗坏血酸是第一个被鉴定为对SVCTs完全特异而对GLUTs不特异的转运底物,并提供了一种新策略来确定每条途径对抗坏血酸积累的贡献。